Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 331
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00176813 | Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer | ||
| NCT01975597 | Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer | ||
| NCT01477489 | Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer | ||
| NCT00615589 | Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen | ||
| NCT00726180 | Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer | ||
| NCT05162846 | Michigan Genetic Hereditary Testing (MiGHT) | ||
| NCT03781986 | APG-115 in Salivary Gland Cancer Trial | ||
| NCT02734797 | Clinical Outcomes, Nutritional Status, Exercise and Psychosocial Factors in Pediatric Hematopoietic Cell Transplant | ||
| NCT00156273 | Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer | ||
| NCT01190527 | Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer | ||
| NCT01663259 | Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients | ||
| NCT00151073 | Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate | ||
| NCT02277457 | Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations | ||
| NCT04827459 | Sleep Coach: A Mobile App to Address Insomnia Symptoms Among Cancer Survivors | ||
| NCT06941324 | Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors | ||
| NCT01750567 | A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL | ||
| NCT07645391 | Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer | ||
| NCT00151060 | Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate | ||
| NCT04754399 | Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias | ||
| NCT00156312 | Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine | ||
| NCT00794547 | Phase I/II Calcitriol in Lung Cancer | ||
| NCT00176748 | Treatment for Patients With Metastatic Thyroid Cancer | ||
| NCT03240016 | Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer | ||
| NCT00148109 | Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas | ||
| NCT04595851 | Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications | ||
| NCT01457885 | Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen | ||
| NCT06100263 | Breast Cancer Resiliency Through Exercise Program (B-REP) | ||
| NCT04051216 | The SMART CART Study: Health Information Technology | ||
| NCT06356155 | Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer | ||
| NCT04574856 | Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma | ||
| NCT06539468 | Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients | ||
| NCT02031237 | MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy | ||
| NCT00645593 | Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer | ||
| NCT03101566 | Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer | ||
| NCT00843375 | Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas | ||
| NCT02037230 | Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas | ||
| NCT04845035 | Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia | ||
| NCT05691400 | Phase IV Multi-arm Study of CDK4/6 Pharmacokinetics in Healthy Volunteers With Known CYP3A4*22 Genotype | ||
| NCT04194554 | A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer | ||
| NCT00393796 | Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma | ||
| NCT00148070 | Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer | ||
| NCT03689582 | Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate Cancer | ||
| NCT04431635 | Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma | ||
| NCT04518748 | Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy. | ||
| NCT02783950 | Genomics in Michigan Impacting Observation or Radiation | ||
| NCT00644683 | A Pilot Observational Study to Assess Changes in Biochemical Parameters of Ovarian Reserve With Chemotherapy | ||
| NCT00230399 | Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer | ||
| NCT00637390 | A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer. | ||
| NCT02677948 | Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) | ||
| NCT05866302 | Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients |
